In fact, Busquets et al. and Constantinou et al. demonstrated that a cancer-bearing rat model exhibited significantly more pronounced skeletal muscle atrophy compared with the control group rats, and the expression of UCP2 and UCP3 in skeletal muscles was significantly upregulated [13, 14]. This evidence concerns the gene UCP2 and cancer.